It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Claudin family tight junction proteins form charge- and size-selective paracellular channels that regulate epithelial barrier function. In the gastrointestinal tract, barrier heterogeneity is attributed to differential claudin expression. Here, we show that claudin-23 (CLDN23) is enriched in luminal intestinal epithelial cells where it strengthens the epithelial barrier. Complementary approaches reveal that CLDN23 regulates paracellular ion and macromolecule permeability by associating with CLDN3 and CLDN4 and regulating their distribution in tight junctions. Computational modeling suggests that CLDN23 forms heteromeric and heterotypic complexes with CLDN3 and CLDN4 that have unique pore architecture and overall net charge. These computational simulation analyses further suggest that pore properties are interaction-dependent, since differently organized complexes with the same claudin stoichiometry form pores with unique architecture. Our findings provide insight into tight junction organization and propose a model whereby different claudins combine to form multiple distinct complexes that modify epithelial barrier function by altering tight junction structure.
Claudin family proteins are important for regulating epithelial barrier function. Here the authors show that claudin-23 controls paracellular flux by combining with other claudins to alter tight junction architecture and permeability.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Lozada-Soto, Kristen M. 1
; Rajagopal, Nandhini 2 ; Garcia-Hernandez, Vicky 1
; Luissint, Anny-Claude 1
; Brazil, Jennifer C. 1 ; Cui, Guiying 3 ; Koval, Michael 4
; Parkos, Charles A. 1
; Nangia, Shikha 2
; Nusrat, Asma 1
1 University of Michigan Medical School, Department of Pathology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
2 Syracuse University, Department of Biomedical and Chemical Engineering, Syracuse, USA (GRID:grid.264484.8) (ISNI:0000 0001 2189 1568)
3 Emory University School of Medicine, Department of Pediatrics, Emory + Children’s Center for Cystic Fibrosis and Airways Disease Research, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
4 Emory University School of Medicine, Departments of Medicine and Cell Biology, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)




